Hindustan Laboratories Limited (New IPO): GMP, Profit, Price & expert review
Hindustan Laboratories Limited is an Indian pharmaceutical company primarily engaged in the large-scale manufacturing and supply of generic medicines, especially under business-to-government (B2G) contracts for central and state government healthcare agencies.
Hindustan Laboratories has filed DRHP with SEBI for a proposed IPO with an issue size of 14,100,000 Equity Shares consisting Fresh Issue of 5,000,000 Equity Shares & Offer for Sale (OFS) of 9,100,000 Equity Shares.
